Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 6/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PTGDR | Q13258 | 3/20 | 0.30 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19201307 | 1.00 | PTGDR2 (0.33) | PTGDR2LMNAPTGDRPTGER2 | |
| SCHEMBL30153489 | 1.00 | PTGDR2 (0.33) | PTGDR2LMNAPTGDRPTGER2 | |
| SCHEMBL31650890 | 0.98 | PTGDR2 (0.30) | PTGDR2 | |
| SCHEMBL13464242 | 0.85 | HTT (0.32) | — | |
| SCHEMBL15078950 | 0.85 | NPSR1 (0.31) | — | |
| SCHEMBL18106103 | 0.85 | — | — | |
| SCHEMBL22207757 | 0.84 | BBOX1 (0.33) | — | |
| SCHEMBL13154130 | 0.83 | CES2 (0.32) | — | |
| SCHEMBL17525150 | 0.83 | LMNA (0.36) | PTGDR2LMNA | |
| SCHEMBL18958958 | 0.82 | EPHX2 (0.36) | PTGDR2PTGDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9981997-B2 | Chemical reagents for attaching affinity molecules on surfaces | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2018-05-29 | — | — | US | claimed |
| US-20160280723-A1 | CHEMICAL REAGENTS FOR ATTACHING AFFINITY MOLECULES ON SURFACES | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2016-09-29 | — | — | US | claimed |
| CN-104672484-A | Cross-linked polysaccharide tissue engineering porous scaffold preparation method | UNIV NANJING SCIENCE & TECH | 2015-06-03 | — | — | CN | claimed |
| EP-3946460-B1 | IMPROVED CONJUGATION LINKERS | PROLYNX LLC (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-3125943-B1 | PHOSPHATE BASED LINKERS FOR INTRACELLULAR DELIVERY OF DRUG CONJUGATES | MERCK SHARP & DOHME LLC (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260020859-A1 | MATERIALS FOR CONFORMABLE FILLABLE MEDICAL BALLOONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-01-22 | — | — | US | disclosed |
| US-20260021223-A1 | HYDROGEL FILLERS FOR CONFORMABLE FILLABLE MEDICAL BALLOONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-01-22 | — | — | US | disclosed |
| US-20260007768-A1 | CONJUGATION LINKERS | PROLYNX LLC (US) | 2026-01-08 | — | — | US | disclosed |
| US-20250248935-A1 | SYSTEMS AND METHODS FOR ON-DEMAND CLEAVAGE OF HYDROGELS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-08-07 | — | — | US | disclosed |
| US-12364771-B2 | Conjugation linkers | PROLYNX LLC (US) | 2025-07-22 | — | — | US | disclosed |
| US-12312574-B2 | Polymer-coated crosslinked alginate gel fiber | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2025-05-27 | — | — | US | disclosed |
| US-7807619-B2 | cycloalkyne compounds reacting with an azide moiety on a target biomolecule, by biochemical conjugation; for its application in vivo (on the cell surface or intracellularly) or in vitro (synthesis of peptides); labeling | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-10-05 | — | — | US | disclosed |
| US-7807619-B2 | cycloalkyne compounds reacting with an azide moiety on a target biomolecule, by biochemical conjugation; for its application in vivo (on the cell surface or intracellularly) or in vitro (synthesis of peptides); labeling | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-10-05 | — | — | US | disclosed |
| WO-2010106246-A1 | METHOD FOR SURFACE FUNCTIONALISATION BY DISUBSTITUTED ALKYNES | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2010-09-23 | — | — | WO | disclosed |
| WO-2010106245-A1 | NOVEL BIFUNCTIONAL MOLECULES COMPRISING A CYCLOALKYNE OR HETEROCYCLOALKYNE GROUP AND A REDOX GROUP | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2010-09-23 | — | — | WO | disclosed |
| US-20100200813-A1 | SEMICONDUCTOR NANOCRYSTALS | COMMISSARIAT A L' ENERGIE ATOMIQUE (FR) | 2010-08-12 | — | — | US | disclosed |
| US-20100200813-A1 | SEMICONDUCTOR NANOCRYSTALS | COMMISSARIAT A L' ENERGIE ATOMIQUE (FR) | 2010-08-12 | — | — | US | disclosed |
| EP-2161239-A1 | Semiconductor nanocrystals | Commissariat à l'Energie Atomique (FR) | 2010-03-10 | — | — | EP | disclosed |
| US-20090068738-A1 | COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-03-12 | — | — | US | disclosed |
| US-20090068738-A1 | COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250248935-A1 | SYSTEMS AND METHODS FOR ON-DEMAND CLEAVAGE OF HYDROGELS | PLG, FGB, ADAM33 | PTGDR2 2305/4885LMNA 117/4885PTGDR 2297/4885 |
| US-20260021223-A1 | HYDROGEL FILLERS FOR CONFORMABLE FILLABLE MEDICAL BALLOONS | H1-5, H1-2, H1-3 | PTGDR2 1725/4885LMNA 1262/4885PTGDR 1972/4885 |
| US-20260020859-A1 | MATERIALS FOR CONFORMABLE FILLABLE MEDICAL BALLOONS | SMCHD1, KDM8, H1-5 | PTGDR2 1806/4885LMNA 1485/4885PTGDR 2003/4885 |
| US-20090068738-A1 | COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES | PTMS, QPCT, ANPEP | PTGDR2 1144/4885LMNA 1871/4885PTGDR 458/4885 |
| US-20260007768-A1 | CONJUGATION LINKERS | OGFR, SLC43A1, ILK | PTGDR2 1336/4885LMNA 3011/4885PTGDR 590/4885 |
| US-20160280723-A1 | CHEMICAL REAGENTS FOR ATTACHING AFFINITY MOLECULES ON SURFACES | EPCAM, ICAM1, SELE | PTGDR2 1836/4885LMNA 3359/4885PTGDR 1882/4885 |
| US-12364771-B2 | Conjugation linkers | DNPEP, FGB, VIP | PTGDR2 3785/4885LMNA 2524/4885PTGDR 3384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.